EUVIMEDEUVIMED entdecken
Crossref

MREDTA : A BERT and transformer‐based molecular representation encoder for predicting drug‐target binding affinity

Xu Sun iD, Juanjuan Huang iD, Yabo Fang iD, Yixuan Jin iD, Jiageng Wu iD, Guoqing Wang iD, Jiwei Jia iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202401254r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Xu Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational Mathematics, School of Mathematics, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: the Fundamental Research Funds for the Central Universities, JLU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug‐target binding affinity (DTA) prediction is vital for drug repositioning. The accuracy and generalizability of DTA models remain a major challenge. Here, we develop a model composed of BERT‐Trans Block, Multi‐Trans Block, and DTI Learning modules, referred to as Molecular Representation Encoder‐based DTA prediction (MREDTA). MREDTA has three advantages: (1) extraction of both local and global molecular features simultaneously through skip connections; (2) improved sensitivity to molecular structures through the Multi‐Trans Block; (3) enhanced generalizability through the introduction of BERT. Compared with 12 advanced models, benchmark testing of KIBA and Davis datasets demonstrated optimal performance of MREDTA. In case study, we applied MREDTA to 2034 FDA‐approved drugs for treating non‐small‐cell lung cancer (NSCLC), all of which act on mutant EGFR T790M protein. The corresponding molecular docking results demonstrated the robustness of MREDTA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationHumansCarcinoma, Non-Small-Cell LungDrug RepositioningLung NeoplasmsErbB ReceptorsProtein BindingAntineoplastic Agents

Stichwörter der Autor:innen

BERTDTAdrug repositioningmulti‐transtransformer encoder

Substanzen

ErbB ReceptorsAntineoplastic AgentsEGFR protein, human

Autor:innen und Institutionen

  • Department of Computational Mathematics, School of Mathematics, Jilin University, Changchun, China.
  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, College of Basic Medicine, Jilin University, Changchun, China.
  • Jilin National Applied Mathematical Center, Jilin University, Changchun, China.

ORCID-Profile: Xu Sun, Juanjuan Huang, Yabo Fang, Yixuan Jin, Jiageng Wu, Guoqing Wang, Jiwei Jia

Förderung

  • the Fundamental Research Funds for the Central Universities, JLU

Zitieren

APA

Sun, X., Huang, J., Fang, Y., Jin, Y., Wu, J., Wang, G., & Jia, J. (2024). MREDTA : A BERT and transformer‐based molecular representation encoder for predicting drug‐target binding affinity. The FASEB Journal. https://doi.org/10.1096/fj.202401254r

Vancouver

Sun X, Huang J, Fang Y, Jin Y, Wu J, Wang G, et al. MREDTA : A BERT and transformer‐based molecular representation encoder for predicting drug‐target binding affinity. The FASEB Journal. 2024. doi:10.1096/fj.202401254r

BibTeX
@article{Sun2024,
  author = {Sun, Xu and Huang, Juanjuan and Fang, Yabo and Jin, Yixuan and Wu, Jiageng and Wang, Guoqing and Jia, Jiwei},
  title = {MREDTA : A BERT and transformer‐based molecular representation encoder for predicting drug‐target binding affinity},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202401254r}
}
Kostenlos starten →